Gastrogastric Fistula: It May not be as Bad as it Sounds!!!
Gastrogastric Fistula: It May not be as Bad as it Sounds!!!
Abstract & Commentary
By Amir Mehran, MD, FACS, Assistant Clinical Professor of Surgery; Director Bariatric Surgery, Section for Minimally Invasive and Bariatric Surgery, Department of Surgery, UCLA. Dr. Mehran reports no financial relationships relevant to this field of study.
Synopsis: Weight loss failure or weight regain is an uncommon short-term finding with gastrogastric fistulas after divided RYGB that requires surgical revision as the definitive treatment option.
Source: Carrodeguas L, et al. Management of gastrogastric fistulas after divided Roux en-Y gastric bypass surgery for morbid obesity: Analysis of 1,292 consecutive patients and review of literature. Surg Obes Relat Dis. 2005;1:467-474.
To hear, "there is contrast in the gastric remnant" was the last thing I expected after my patient in the ER had had a CT scan performed for abdominal pain. This cannot be a gastrogastric fistula (GGF), could it? After all, she was only 2 weeks postop from an uncomplicated, fully-transected laparoscopic Roux en-Y gastric bypass (LRYGB). Ok, so she did ignore postoperative instructions, ate a very spicy semi-solid lunch, developed immediate severe abdominal pain, and did not report if for 4 days. But a GGF this early? How did that happen and what do I do now??
GGF is a well-known complication of the RYGB, occurring in 1-6% of cases. Its exact incidence, however, is unknown, as a significant number of patients remain asymptomatic. It is believed that the incidence has declined over the years. This has been attributed to the modification of the surgical technique where, in contrast to the past, the stomach is now completely transected rather than just stapled off in continuity. The etiology of GGF includes contained anastomotic leaks, marginal ulcers ± perforation, foreign body erosion, incomplete gastric division at original operation, and possible gastric wall tissue migration.1 The typical presenting symptoms, if any, are abdominal pain, intractable marginal ulcers secondary to acid backwash, and weight regain secondary to loss of restriction. Whereas most patients are managed conservatively, some do require more aggressive treatment modalities, either endoscopic or surgical. The former have included various plugs, medical glue, endoscopic clips or suturing techniques. Depending on the etiology and size of the GGF, these techniques have had variable success rates.
One surgical approach has been published by Roberts and colleagues from Yale University.2 In one patient, a gastrotomy was made in the gastric remnant followed by endoscopic introduction of pneumogastrium and transgastric suturing of the GGF. However, the follow-up was only 18 months, and there have been no other similar reports.
The Bariatric Surgery Institute at the Cleveland Clinic in Florida has published the 2 most detailed papers about GGF and its surgical management.1, 3 In 2005, the authors presented their experience with over 1200 patients. They identified GGFs in 15 (1.2%) of these subjects. The mean time to GGF diagnosis was 80 days and ranged from 3 days to one year post-operation. Abdominal pain and nausea or vomiting were the most common symptoms, followed by weight regain. Imaging and endoscopic studies were confirmatory in all patients. Of interest, 4 patients had had a known postoperative gastrojejunostomy leak that had been treated conservatively. GGF was associated with marginal ulcers in 8 of these subjects, most of whom responded to medical therapy (proton pump inhibitor and sucralfate). The authors also presented a concise treatment algorithm for GGF, and emphasized the need for aggressive follow-up to include gastrointestinal imaging and endoscopy for the presence of any abdominal pain symptoms or weight regain.
In a follow-up paper published recently,3 the same group presented their unique surgical approach to the management of GGF in 15 patients who failed conservative management. In the laparoscopic remnant gastrectomy, the fistula tract was transected with an endoscopic stapler, the pouch was trimmed, if necessary, and finally the gastric remnant was excised and removed. The authors believe that the final step is very necessary. The number of gastric-producing cells is reduced, decreasing the odds of pouch acid production and hence, future marginal ulcerations and strictures. Furthermore, this technique prevents future GGF formation by removing inflammatory tissue from the current GGF basin, reducing the possibility of gastric wall migration or new GGF formation. The authors do point out several flaws in their study, namely the small number of patients, short follow-up period, and possibility of future complications from remnant gastrectomy.
So how did we manage our GGF patient? She was placed on a high protein liquid diet, sucralfate, every 3 to 4 hours, and a proton pump inhibitor twice daily. Her pain symptoms resolved within 48 hours, and at 2 weeks, she remains pain free and is losing weight. We are only debating on whether we need to restudy her at any point with an imaging modality and, if so, when??
References
1) Carrodeguas, L. et al. Management of gastrogastric fistulas after divided Roux en-Y gastric bypass surgery for morbid obesity: Analysis of 1,292 consecutive patients and review of literature. Surg Obes Relat Dis. 2005;1:467-474.
2) Roberts, KE, et al. Laparoscopic transgastric repair of a gastrogastric fistula after gastric bypass: A novel technique. Surg Innov. 2007;14:18-23.
3) Cho, M. et al. Laparoscopic remnant gastrectomy: A novel approach to gastrogastric fistula after Roux-en-Y gastric bypass for morbid obesity. J Am Coll Surg. 2007;204:617-624.
Weight loss failure or weight regain is an uncommon short-term finding with gastrogastric fistulas after divided RYGB that requires surgical revision as the definitive treatment option.Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.